{"id":"https://openalex.org/W2104807526","doi":"https://doi.org/10.1158/1535-7163.mct-12-1188","title":"Glycolysis Inhibition Sensitizes Non\u2013Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation","display_name":"Glycolysis Inhibition Sensitizes Non\u2013Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation","alternate_titles":[],"publication_year":2013,"publication_date":"2013-10-01","ids":{"openalex":"https://openalex.org/W2104807526","doi":"https://doi.org/10.1158/1535-7163.mct-12-1188","mag":"2104807526","pmid":"https://pubmed.ncbi.nlm.nih.gov/23883584"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-12-1188","doi":"https://doi.org/10.1158/1535-7163.mct-12-1188","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-12-1188","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2104807526"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://mct.aacrjournals.org/content/12/10/2145.long","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100778145","display_name":"Sun Mi Kim","orcid":"https://orcid.org/0000-0003-4562-2869","observed_orcids":["https://orcid.org/0000-0003-4562-2869"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["AT","KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sun Mi Kim","raw_affiliation_strings":["Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210119669","https://openalex.org/I4405258038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011458812","display_name":"Mi Ran Yun","orcid":"https://orcid.org/0000-0002-2398-3287","observed_orcids":["https://orcid.org/0000-0002-2398-3287"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["AT","KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mi Ran Yun","raw_affiliation_strings":["Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210119669","https://openalex.org/I4405258038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004798515","display_name":"Yun Kyoung Hong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["AT","KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yun Kyoung Hong","raw_affiliation_strings":["Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210119669","https://openalex.org/I4405258038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070801716","display_name":"Flavio Solca","orcid":"https://orcid.org/0000-0001-8756-2046","observed_orcids":["https://orcid.org/0000-0001-8756-2046"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["AT","KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Flavio Solca","raw_affiliation_strings":["Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210119669","https://openalex.org/I4405258038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005188570","display_name":"Joo-Hang Kim","orcid":"https://orcid.org/0000-0003-0408-8997","observed_orcids":["https://orcid.org/0000-0003-0408-8997"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["AT","KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joo-Hang Kim","raw_affiliation_strings":["Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210119669","https://openalex.org/I4405258038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100436425","display_name":"Hyun Jung Kim","orcid":"https://orcid.org/0009-0002-3589-5847","observed_orcids":["https://orcid.org/0009-0002-3589-5847"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["AT","KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hyun-Jung Kim","raw_affiliation_strings":["Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210119669","https://openalex.org/I4405258038"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064697305","display_name":"Byoung Chul Cho","orcid":"https://orcid.org/0000-0002-5562-270X","observed_orcids":["https://orcid.org/0000-0002-5562-270X"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["AT","KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Byoung Chul Cho","raw_affiliation_strings":["Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Brain Korea 21 Project for Medical Sciences; 2Institute for Cancer Research, Yonsei Cancer Center, and 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Pharmacology, Boehringer Ingelheim Austria, Vienna, Austria; and 5JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Kyungbuk, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210119669","https://openalex.org/I4405258038"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.7423,"has_fulltext":true,"cited_by_count":103,"citation_normalized_percentile":{"value":0.96541683,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"12","issue":"10","first_page":"2145","last_page":"2156"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8870000243186951},{"id":"https://openalex.org/keywords/egfr-t790m-mutation","display_name":"T790M mutation","score":0.9810000061988831},{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":0.6990000009536743},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7720000147819519},{"id":"https://openalex.org/keywords/2-deoxy-d-glucose","display_name":"2-deoxyglucose","score":0.8939999938011169},{"id":"https://openalex.org/keywords/glycolysis-inhibition","display_name":"glycolysis inhibition","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ampk-activation","display_name":"AMPK activation","score":0.8970000147819519},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.8970000147819519},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.9470000267028809},{"id":"https://openalex.org/keywords/translational-suppression","display_name":"translational suppression","score":0.8320000171661377},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.8479999899864197},{"id":"https://openalex.org/keywords/atp-depletion","display_name":"ATP depletion","score":0.8180000185966492},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8640000224113464}],"concepts":[{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.9515953063964844},{"id":"https://openalex.org/C2780124434","wikidata":"https://www.wikidata.org/wiki/Q12357464","display_name":"AMPK","level":4,"score":0.8278231620788574},{"id":"https://openalex.org/C2777930144","wikidata":"https://www.wikidata.org/wiki/Q25100112","display_name":"T790M","level":5,"score":0.7872694730758667},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5492508411407471},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5192627906799316},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.4366466701030731},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.424263596534729},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41627028584480286},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.41532862186431885},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3894347548484802},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3643794655799866},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.35416364669799805},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3094393014907837},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27025261521339417},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22778069972991943},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19457966089248657},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.15382400155067444}],"mesh":[{"descriptor_ui":"D000077716","descriptor_name":"Afatinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003847","descriptor_name":"Deoxyglucose","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006019","descriptor_name":"Glycolysis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014176","descriptor_name":"Protein Biosynthesis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D055372","descriptor_name":"AMP-Activated Protein Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D064549","descriptor_name":"Myeloid Cell Leukemia Sequence 1 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D064549","descriptor_name":"Myeloid Cell Leukemia Sequence 1 Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-12-1188","doi":"https://doi.org/10.1158/1535-7163.mct-12-1188","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-12-1188","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:23883584","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23883584","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:ir.ymlib.yonsei.ac.kr:22282913/88759","doi":null,"is_oa":true,"landing_page_url":"https://ir.ymlib.yonsei.ac.kr/handle/22282913/88759","pdf_url":"http://mct.aacrjournals.org/content/12/10/2145.long","source":{"id":"https://openalex.org/S4306400691","display_name":"YUHSpace (Yonsei University Medical Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193775966","host_organization_name":"Yonsei University","host_organization_lineage":["https://openalex.org/I193775966"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:ir.ymlib.yonsei.ac.kr:22282913/88759","doi":null,"is_oa":true,"landing_page_url":"https://ir.ymlib.yonsei.ac.kr/handle/22282913/88759","pdf_url":"http://mct.aacrjournals.org/content/12/10/2145.long","source":{"id":"https://openalex.org/S4306400691","display_name":"YUHSpace (Yonsei University Medical Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193775966","host_organization_name":"Yonsei University","host_organization_lineage":["https://openalex.org/I193775966"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322120","display_name":"National Research Foundation of Korea","ror":"https://ror.org/013aysd81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2104807526.pdf","grobid_xml":"https://content.openalex.org/works/W2104807526.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W1859354334","https://openalex.org/W1964321121","https://openalex.org/W1971392223","https://openalex.org/W1975540192","https://openalex.org/W1988363759","https://openalex.org/W1988377311","https://openalex.org/W1991249033","https://openalex.org/W1991429659","https://openalex.org/W1992018638","https://openalex.org/W1993283403","https://openalex.org/W2002937040","https://openalex.org/W2005204942","https://openalex.org/W2010538519","https://openalex.org/W2017134992","https://openalex.org/W2028268047","https://openalex.org/W2029067546","https://openalex.org/W2039633811","https://openalex.org/W2044874695","https://openalex.org/W2055386000","https://openalex.org/W2059623168","https://openalex.org/W2060347270","https://openalex.org/W2062547838","https://openalex.org/W2063391304","https://openalex.org/W2065825082","https://openalex.org/W2072451938","https://openalex.org/W2076767106","https://openalex.org/W2087877138","https://openalex.org/W2092353041","https://openalex.org/W2093579930","https://openalex.org/W2093826193","https://openalex.org/W2094844488","https://openalex.org/W2107026633","https://openalex.org/W2110841878","https://openalex.org/W2121727754","https://openalex.org/W2123122199","https://openalex.org/W2123244357","https://openalex.org/W2132889264","https://openalex.org/W2136272779","https://openalex.org/W2138604360","https://openalex.org/W2143225176","https://openalex.org/W2150351516","https://openalex.org/W2150419930","https://openalex.org/W2152876030","https://openalex.org/W2152905269","https://openalex.org/W2159717790","https://openalex.org/W2168330194","https://openalex.org/W2168919362","https://openalex.org/W2169816570","https://openalex.org/W2399122692","https://openalex.org/W2914002569","https://openalex.org/W6638819146","https://openalex.org/W6654640476","https://openalex.org/W6712353045"],"related_works":["https://openalex.org/W2000047964","https://openalex.org/W1526893002","https://openalex.org/W2096639900","https://openalex.org/W2766992875","https://openalex.org/W2040575339","https://openalex.org/W1999154148","https://openalex.org/W4233187888","https://openalex.org/W2066128027","https://openalex.org/W2170532460","https://openalex.org/W1490323181"],"abstract_inverted_index":{"The":[0,131,159],"secondary":[1,239],"EGF":[2],"receptor":[3],"(EGFR)":[4],"T790M":[5,197],"is":[6,221],"the":[7,42,62,70,85,116,119,127,134,139,152,169,181,199,202,210,227],"most":[8],"common":[9],"mechanism":[10],"of":[11,64,72,87,104,118,129,133,141,147,151,161,183,201,213,216,229],"resistance":[12,233],"to":[13,40,190,234,238],"reversible":[14,235],"EGFR-tyrosine":[15],"kinase":[16,107],"inhibitors":[17],"(TKI)":[18],"in":[19,49,74,95,102,115,168,170,192],"patients":[20,230],"with":[21,27,80,84,122,195,231],"non-small":[22],"cell":[23],"lung":[24],"cancer":[25],"(NSCLC)":[26],"activating":[28],"EGFR":[29,81,196,240],"mutations.":[30],"Although":[31],"afatinib":[32,73,90,125,162,191,220],"(BIBW2992),":[33],"a":[34,50,112,149,222],"second-generation":[35],"irreversible":[36],"EGFR-TKI,":[37],"was":[38,166],"expected":[39],"overcome":[41],"acquired":[43,232],"resistance,":[44],"it":[45],"showed":[46],"limited":[47],"efficacy":[48,71],"recent":[51],"phase":[52],"III":[53],"clinical":[54],"study.":[55],"In":[56,175],"this":[57,177],"study,":[58],"we":[59],"found":[60],"that":[61,209],"inhibition":[63,128,140,182],"glycolysis":[65],"using":[66,186],"2-deoxy-d-glucose":[67],"(2DG)":[68],"improves":[69],"H1975":[75,97],"and":[76,89,98,124,219],"PC9-GR":[77,99,172],"NSCLC":[78,193],"cells":[79,194],"T790M.":[82,241],"Treatment":[83],"combination":[86],"2DG":[88,123,165,187],"induced":[91,144],"intracellular":[92],"ATP":[93],"depletion":[94],"both":[96],"cells,":[100],"resulting":[101],"activation":[103,110],"AMP-activated":[105],"protein":[106],"(AMPK).":[108],"AMPK":[109],"played":[111],"central":[113],"role":[114],"cytotoxicity":[117],"combined":[120,211],"treatment":[121,228],"through":[126,156,198],"mTOR.":[130],"alteration":[132],"AMPK/mTOR":[135],"signaling":[136,204],"pathway":[137],"by":[138,164],"glucose":[142,184,217],"metabolism":[143,185,218],"specific":[145],"downregulation":[146],"Mcl-1,":[148],"member":[150],"antiapoptotic":[153],"Bcl-2":[154],"family,":[155],"translational":[157],"control.":[158],"enhancement":[160],"sensitivity":[163,189],"confirmed":[167],"vivo":[171],"xenograft":[173],"model.":[174],"conclusion,":[176],"study":[178],"examined":[179],"whether":[180],"enhances":[188],"regulation":[200],"AMPK/mTOR/Mcl-1":[203],"pathway.":[205],"These":[206],"data":[207],"suggest":[208],"use":[212],"an":[214],"inhibitor":[215],"potential":[223],"therapeutic":[224],"strategy":[225],"for":[226],"EGFR-TKIs":[236],"due":[237]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2104807526","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
